Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Clinical trial NCT05758493 · RECRUITING
Trial details
- NCT number
- NCT05758493
- Sponsor
- Oregon Health and Science University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2027-12-10
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.